Clinical Trial Update: Study Evaluating the Efficacy and Safety of Darolutamide and Stereotactic Dose Escalated Radiotherapy in Patients With Localized Prostate Cancer and High-risk Features of Relapse [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial is evaluating the combination of darolutamide with stereotactic dose-escalated radiotherapy in men with localized prostate cancer an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)

Snippet

Sponsor: UNICANCER | Conditions: High Risk Prostate Carcinoma, Prostate Cancer | Phase 3 | Status: RECRUITING